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1. Introduction 
The calcium-dependent aspects of such diverse 
processes as contraction, secretion and nerve function 
seem to be mediated by the ubiquitous calcium 
receptor protein, calmodulin (CaM) ,[ l]. Another 
well-established, calcium-dependent process is cell 
proliferation both in vivo and in vitro [2]. Whether 
CaM is involved with this action of calcium remains 
unclear. However several ines of evidence suggest 
that this calcium receptor protein does have some 
function in the control of cell proliferation: 
(i) An increase in CaM has been found in a tumour 
cell line as the cells synchronously enter the 
DNA synthetic phase of the cell cycle [3]; 
(ii) CaM does have the ability to stimulate DNA syn- 
thesis in isolated liver cells [4]; 
(iii) Many cell lines when transformed by tumour 
viruses have increased amounts of CaM [5-71. 
This report submits evidence for the first time of a 
change in CaM during growth of normal liver, regen- 
erating in vivo, and a greater content of CaM in many 
solid tumours of liver. 
2. Materials and methods 
Partial hepatectomy (68%) was performed between 
7:0 and 10:0 pm [8] on specific-pathogen free, male, 
Sprague-Dawley rats (190-230 g). Fetal and neonatal 
livers were also from Sprague-Dawley stock. 
Morris hepatomas 5123tc, 5123tch, 7288tc and 
7795 were maintained in this laboratory as in [9] 
using Buffalo rats (Microbiological Assoc., Walkersville 
NRCC no. 19638 
MD). The other Morris hepatomas were supplied from 
Howard University (Washington DC). The Yoshida, 
Novikoff and LC-I 8 hepatomas were from the Mason 
Research Institute Tumour Bank (Worcester MA). 
Tissues to be assayed for CaM were excised and 
immediately homogenised (1: 10, w/v) in the ice-cold 
isolation medium (150 mM NaCl, 10 mM MgC12, 
10 mM imidazole, 1 mM EGTA, 1 mM mercapto- 
ethanol, pH 7.5). After a sample of the total homog- 
enate was removed for total CaM assay, the remainder 
was centrifuged at 105 000 X g for 30 min in a 
Beckman L265B centrifuge. The particulate pellet 
was washed, recentrifuged and diluted to the original 
volume with isolation medium. Total, soluble and 
particulate samples were heated for 5’min to 8O”C, 
rapidly cooled, sonicated, and re-centrifuged at 
105 000 X g. The resulting extracts were stored at 
-8O’C to await assay. 
The radioimmunoassay for CaM was based on pro- 
cedures in [ 10,111. Rat testicular CaM was purified to 
homogeneity [ 121, and an antiserum raised in sheep 
using performic acid oxidised material [ 131. The 
sheep were bled after a series of CaM inoculations 
consisting of 5 mg on day 0 and 2 mg on days 11 and 
24. The crude immunoglobulins [ 141 were passed 
through a column of DEAE-Affigel blue (BioRad, 
Mississauga, Ont.). The material not binding to the 
column was dialysed against 100 mM boric acid, 
25 mM sodium borate, 75 mM NaCl (PH 8.4). The 
anti-CaM immunoglobulin in this fraction was 
absorbed by antigen affinity chromatography on 
CaM-Sepharose [ 151 and eluted with 100 mM gly- 
tine (pH 2.7) [lo]. The eluate was neutralised imme- 
diately and dialysed against 100 mM NaCl, 10 mM 
imidazole (pH 7.4). 
CaM was iodinated with the ‘251-labeled Bolton- 
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Hunter reagent (Amersham, Oakville, Ont.) which 
yielded 120 000 cpm/ng CaM. The radioimmuno- 
assay was performed in a final volume of 500 ~1 RIA 
buffer (75 mM NaCl, 1 mM EGTA, 125 mM Tris, 
20 pg/ml bovine serum albumin (pH 8.4)) containing 
40 000 cpm 1251-labeled CaM, 2 I-18 anti-CaM, and 
standard amounts of CaM, or tissue extracts. The 
tubes were incubated at room temperature for 2 h, 
and then at 4°C for 20 h before precipitation of the 
immune complex with 1 ml Pluronic F-38 (BASF, 
Rexdale, Ont.) at a final concentration of 14% (w/v) 
following centrifugation at 6000 X g for 30 min. The 
precipitates were counted in a Beckman Biogamma 
counter. 
A typical standard curve is illustrated in fig.1 A. An 
excess of rat parvalbumin, or bovine lactalbumin did 
not displace CaM from the antibody. However, rabbit 
skeletal muscle troponin C did show some cross-reac- 
tivity at 5000 ng/tube (fig.lA). Such an interaction 
of troponin C with anti-CaM antisera was reported in 
[ 11,131. Also illustrated in fig.lA is the ability of 
serially diluted liver extract to cross-react in a parallel 
fashion with the anti-CaM antisera. Such a parallel 
displacement indicated the presence in the liver 
extract of CaM or an immunologically very similar 
material [ 11 ,131. 
CaM content was also measured by stimulation of 
a cyclic-nucleotide phosphodiesterase [ 11. CaM deli- 
cient phosphodiesterase was purified from rat heart 
and assayed as in [ 161. The extent of stimulation of 
the enzyme by known amounts of CaM is shown in 
fig.1 B. 
DNA synthesis was measured autoradiographically 
in rats injected with [3H] TdR [ 171. 
3. Results and discussion 
The CaM content of either the soluble or particu- 
late fraction of liver did not change after sham hepa- 
tectomy. However when 68% partial hepatectomy 
was performed, the CaM content of the soluble frac- 
tion of the liver remnant increased between 6-8 h 
following surgery, and reached a peak concentration 
which was 3-fold higher than control (fig.2A). The 
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Fig.1. The measurement of calmodulin content by (A) radioimmunoassay and (B) PDE activation: (A) (o-o) CaM; (o-o) 
parvalbumin or lactalbumin; (*---0) troponin C. Samples of tissue extracts were assayed in triplicate at at least two different 
dilutions. (B) (O---O) CaM. Tissue extracts were assayed in duplicate at at least 3 different dilutions. 
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Fig.2. Changes in the particulate and soluble calmodulin con- 
tents of regenerating liver as determined by radioimmuno- 
assay and PDE activation. Values are the mean t SEM of 
between 4-12 separate animals. 
CaM content then returned to normal by 18 h, which 
was shortly before the synthesis of DNA began 
(fig.2A). No change occurred in the particulate frac- 
tion of regenerating liver (fig.2A). 
Although the radioimmunoassay was considered 
specific for CaM (see section 2), other proteins have 
been reported that cross-react with antiCaM antisera 
[ 18,19]. Therefore the soluble fractions of regenerat- 
ing liver were also tested for their ability to activate 
CaM-dependent cyclic nucleotide phosphodiesterase. 
This assay confirmed that CaM increased during liver 
regeneration (fig.,2B), although the absolute amounts 
of CaM were lower than obtained with radioimmuno- 
assay. This underestimate by the phosphodiesterase 
activation assay has been observed by others [ 111. 
The time when CaM increased during liver regener- 
ation (fig.2) coincides with the time when calcium is 
required for the initiation of DNA synthesis [ 171. A 
similar late prereplicative requirement for calcium has 
been demonstrated for liver cells in vitro [20], which 
also coincides with an increase in cellular CaM [21]. 
The relevance of the CaM rise to the calcium depen- 
dent prereplicative steps remains to be established. 
Besides regenerating liver, the CaM content of 
other in vivo growing tissues of liver origin was mea- 
sured. Fetal or neonatal liver had the same CaM con- 
centration as adult liver. However liver tumours, 
induced by various means, and of different growth 
rates all contained more CaM than normal adult, or 
fetal liver as shown by both radioimmunoassay and 
PDE assay (table 1). 
While this work was in progress, a report appeared 
of an increased CaM content (determined by PDE 
activation) of one Morris hepatoma [22]. It had been 
suggested that although the total CaM content of 
some Morris hepatomas was normal, a redistribution 
occurred causing an increase in the soluble CaM in the 
tumours [23]. These suggestions, plus the extensive 
Table 1 
Calmodulin content of various solid tumours of rat liver 
origin 
Tissue Total CaM (mg/kg) Tumour 
growth 
RIA assay PDE assay ratea 
Liver 
Adultb 
Neonatal, 2 day 
Fetal, 8 day 
78 it 5 (20) 
80 + 7 (3) 
71 f 9 (6) 
Hepatoma 
Morris 7288Ctc 
5 123tcg 
5123tc 
3683Ftc 
8994 
7288C 
8995 
28A 
5123C 
7800 
7794A 
7795 
21 
7787 
9618A 
217 * 27 (12) 60 2 
220 * 31 (8) _ 2-3 
200 * 85 (20) 125 3-4 
207 t 19 (6) 200 4 
361 f 44 (6) 200 4 
186 f 15 (6) 60 4 
275 + 23 (6) 200 6 
170 + 19 (6) 100 8 
201 r 16 (6) - 8-9 
104 + 9 (6) 80 10 
214~ 27 (6) 50 12 
100~ 16 (6) _ 16 
161 ?28 (6) 200 22 
228+ 24 (6) 1.50 30 
202 f 13 (6) 100 48 
YoshidaC 212* 32 (6) 
Novikoff 126 + 17 (6) 
LC-18 357 f49 (6) 
40 
40 - 
40 - 
- - 
100 
150 
a Time in weeks between transfers averaged over 10 genera- 
tions (time in weeks from implantation to the point at 
which tumour extension requires that the host be killed) 
b Buffalo or Sprague-Dawley strain; ’ Carried in host as 
ascites 
Values are mean f SEM (no. separate estimates); PDE assay 
values are the mean of 3 separate estimates 
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data in table 1, combine to demonstrate that the 
increase in CaM content seen in virally transformed 
cells in vitro [ 5-71 may be a general attribute of the 
neoplastic state. Indeed the evidence of an increase in 
CaM in growing normal liver during regeneration sug- 
gests that CaM may somehow be involved with the 
control of cell proliferation. The potential of CaM as 
a growth modulator has been already demonstrated 
by its ability to stimulate DNA synthesis of liver cells 
in vitro [4]. 
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